Michael Trauner

机构：Medical University of Vienna · ORCID：0000-0002-1275-6425

发表论文 3323 篇 · 总被引 69691 次 · h-index 131

代表论文

• Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 11)
• Bile acid signaling in MASLD: From pathogenesis to therapeutic applications (2025 · Hepatology · 被引 10)
• Prevalence of Fibrosis and Applicability of Lab-Based Noninvasive Tests From Primary to Tertiary Care (2025 · Clinical Gastroenterology and Hepatology · 被引 10)
• Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease (2025 · Alimentary Pharmacology & Therapeutics · 被引 9)
• Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis (2025 · Journal of Hepatology · 被引 8)
• Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD (2025 · Journal of Hepatology · 被引 5)